A 54-year-old white male patient was transferred to our hospital for worsening pneumonia. He had been admitted to an outlying hospital with a 1-week history of increasing dyspnea, cough productive of green sputum, and right-sided chest pain associated with night sweats. His medical history was significant for an 80 pack-year smoking history, diabetes mellitus, coronary artery disease, alcohol abuse, and gout. The patient had been self-employed as a logger and worked in the New England region, except for a trip to Tennessee 4 months prior to presentation. A diagnosis of community-acquired pneumonia was made at the outlying hospital, and the patient was begun on a combination of cefazolin and clarithromycin. After 4 days of therapy, the patient had a worsening of symptoms and progression of the radiologic abnormalities, prompting his transfer to our hospital.
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Physical Examination
The patient's vital signs were as follows: temperature, 37.7°C; pulse, 102 beats/min; respiration, 26 breaths/min; and BP, 122/70 mm Hg. The lung examination revealed bilateral coarse crackles. The heart examination was normal except for tachycardia. The abdomen showed a 1-cm eschar with surrounding erythema on the anterior abdominal wall with multiple small papulonodular lesions. The extremities showed no edema or clubbing. A 1-cm eschar with multiple nodular lesions was noted on his left leg.
Laboratory Findings
Laboratory findings were as follows: WBC, 14,000/L with 91% neutrophils; hematocrit, 42%; and creatinine, 0.8. Sputum cultures showed usual oropharyngeal flora. The results of acid-fast bacilli smears, urine Legionella antigen, and blood and urine cultures were negative. A chest radiograph (Fig 1) revealed a multifocal airspace filling process with dense areas of consolidation superimposed on a diffuse background of nodular opacities.
Hospital Course
The patient received a combination of IV ceftriaxone, 2 g qd, and erythromycin, 1 g q6h, along with intermittent noninvasive ventilation with nasal continuous positive airway pressure. After an initial improvement, he became more hypoxemic and hypercapnic, requiring intubation and mechanical ventilation. As the infiltrate continued to progress in spite of therapy, bronchoscopy with BAL was performed on the fifth hospital day to better define the etiology. A periodic acid-Schiff (PAS) diastase stain of the BAL specimen is shown in Figure 2 .
What is the most likely diagnosis?
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Diagnosis: Acute pulmonary blastomycosis
North American blastomycosis is endemic to the southeastern and midwestern United States and was first described by Gilchrist in 1896. Blastomycosis is usually seen in immunocompetent patients, similar to histoplasmosis and coccidioidomycosis.
The respiratory tract is the usual portal of entry, and infection is often associated with outdoor activities like camping, logging, and hunting, where there is contact with moist soil with a high content of organic matter containing the spores. The incubation period can vary from 21 to 106 days. The disease is self-limiting in some patients. In others, inhalation can lead to an acute fulminant pneumonia resulting in the ARDS or can be a chronic pneumonia. A recent case series from Tennessee reported an 11% mortality attributable to ARDS from acute pulmonary blastomycosis (APB). While a history of a sick pet dog could be a clue to the diagnosis, animal to human transmission has been reported only after a bite, and the association with a sick dog simply represents the fact that the dog, being infected in the same manner as humans, was probably exposed to the same environment.
Radiologic features of APB include consolidation and nodules. Cavitation is rare. A focal pulmonary mass mimicking a lung tumor has also been reported. Miliary forms can be confused with tuberculosis.
The disease is often initially treated as communityacquired pneumonia, and frequently an invasive procedure like an open lung or transbronchial biopsy is necessary for the diagnosis. BAL is a good alternative, with organisms demonstrated by silver or PAS stains, or growth by culture.
Immunofluorescent staining may provide confirmation when the number of organisms on histology or culture is small. The serologic tests currently available are limited by insufficient sensitivity, and even the newer tests like enzyme immunoassay and Western blot are probably useful only as screening tests. Two new tests for rapid diagnosis are exoantigen testing and DNA probe. The sensitivity and specificity of these tests are reported to be in the range of 98 to 99%. The skin is the most common extrapulmonary site of infection and dissemination. One interesting feature of the disease has been the relatively small number of patients with the HIV infection in whom blastomycosis has been reported as an opportunistic infection; this could be because these patients may not frequent the environments that are likely to harbor the fungus.
Mild disease, being usually self-limited, does not require treatment. Careful follow-up is indicated, as the disease can relapse at another site, even if the initial infection had been benign. Amphotericin B has been the usual therapy in all patients with moderate or severe primary infection, chronic pulmonary infection, meningeal involvement, or disseminated disease. A total cumulative dose of 2 g lowers the chances of relapse. Early institution of therapy improves outcome. Itraconazole may be an alternative initial treatment in less severely ill patients and in those without meningeal involvement.
The patient's BAL fluid, stained by silver and PAS diastase stains, showed broad-based budding yeast cells consistent with Blastomyces. Stains for acid-fast bacilli, bacteria, and Pneumocystis carinii were negative.
Retrospectively, the patient's family reported that while in Tennessee the patient had been outdoors for extended periods, with an apparently healthy dog. Our patient also had several risk factors for poor response to treatment, including diabetes, smoking, and alcohol abuse. In spite of therapy with high-dose amphotericin B and intensive ventilatory and hemodynamic support, the patient did not improve and died of progressive respiratory failure on the 15th hospital day. An autopsy was declined by the family. 
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